Stay updated on Dupilumab Efficacy in Persistent Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Persistent Asthma Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Persistent Asthma Clinical Trial page
- Check6 days agoChange DetectedThe new screenshot shows the same Study Details page with no changes to core content (e.g., study title, objectives, outcomes, eligibility, locations); only minor formatting differences are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check35 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check43 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.4%

- Check57 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page has updated the citation for a study on Dupilumab efficacy and safety in patients with persistent asthma, reflecting a new version and a change in publication date.SummaryDifference0.6%

- Check71 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with a list of publications related to dupilumab, while removing several outdated terms and categories related to drugs and locations.SummaryDifference5%

Stay in the know with updates to Dupilumab Efficacy in Persistent Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Persistent Asthma Clinical Trial page.